Microbot Medical's Telesurgery Milestone at CRT Annual Meeting
Microbot Medical Inc. Announces Telesurgery Collaboration Breakthrough
Microbot Medical Inc. (NASDAQ: MBOT), known for its groundbreaking LIBERTY Endovascular Robotic System, is proud to disclose a significant milestone achieved in partnership with Corewell Health. This collaboration focuses on advancing the arena of robotic telesurgery, particularly for endovascular applications.
Research Presentation at Cardiovascular Research Technologies Annual Meeting
Under the guidance of Dr. Ryan Madder, who serves as the Section Chief of Interventional Cardiology and Director of the Cardiac Cath Lab at Corewell Health, a comprehensive study is underway. This research examines the feasibility of utilizing the LIBERTY system to conduct simulated cardiovascular interventional procedures at two nearby locations within Corewell Health’s framework.
Highlighted Research Details
The accepted research will be presented at the upcoming Cardiovascular Research Technologies (CRT) conference, scheduled from March 8-11 in Washington D.C. The findings are also set to appear in the Journal of the American College of Cardiology (JACC) Interventions online edition. Key information from the study includes:
- Abstract/Presentation Title: Feasibility of Telerobotic Coronary Artery Wiring Using A Novel Miniaturized Robotic System: A Pre-clinical Ex Vivo Study
- Presenter: Dr. Trisha Gomez
- Date and Time: March 10, 2025, 4:12-4:20 PM ET
- Location: Theater #4
Significance of the Research
Dr. Madder shared insights on the study's implications: "In this study, the LIBERTY robotic system functioned well in a telerobotic setting. The small size and disposable nature of the system open up exciting opportunities for future endovascular procedures across distances." This statement underscores the essential role of robotic systems in enhancing healthcare.
Harel Gadot, the Chairman and CEO of Microbot Medical, added, "This groundbreaking research, led by Dr. Madder and the team at Corewell Health, has been selected for presentation, reflecting the critical importance of integrating telesurgery into the future healthcare landscape. Our commitment to enhancing LIBERTY's capabilities aligns perfectly with these advancements."
Understanding CRT and Its Role
The Cardiovascular Research Technologies conference serves as a principal educational platform for healthcare professionals eager to learn about the latest cardiovascular technologies and techniques. The event attracts interventional cardiologists, surgeons, and clinicians dedicated to advancing cardiovascular medicine through education and innovation.
LIBERTY System’s Development Updates
The telesurgery feature of the LIBERTY system is still in the pipeline at Microbot. It currently does not fall under any pending submissions for FDA 510(k) clearance. This means further development and regulatory reviews are necessary before it can be marketed widely.
About Microbot Medical
Microbot Medical Inc. (NASDAQ: MBOT) stands at the forefront of medical technology innovation. This pre-commercial firm aims to revolutionize healthcare access globally with its unique single-use, fully disposable endovascular robotic system, eliminating traditional restrictions and barriers to advanced healthcare solutions.
For further information about the exciting developments at Microbot Medical, please reach out via email at IR@microbotmedical.com.
Frequently Asked Questions
What innovation is Microbot Medical working on?
Microbot Medical is developing the LIBERTY Endovascular Robotic System, focusing on robotic telesurgery and its applications in cardiovascular medicine.
What is the significance of the study presented at CRT?
This study highlights the feasibility of using robotic technology to perform cardiovascular procedures remotely, showcasing advancements in healthcare technology.
Who is leading the research project?
Dr. Ryan Madder, a prominent figure in interventional cardiology, is spearheading the research project in collaboration with Corewell Health.
Where will the research be presented?
The findings will be presented at the Cardiovascular Research Technologies Annual Meeting in Washington D.C.
How does the LIBERTY system aim to impact healthcare?
By enabling robotic telesurgery, the LIBERTY system is set to enhance access to quality healthcare for patients, especially in remote areas across the globe.
About The Author
Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
